Luca Busino

Luca Busino

Auto-generated profile, based on publicly available information

Luca Busino

Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2021 in Nature
Verified
Journal Article
Closed access
PDF file
DSDaniele Simoneschi
Daniele Simoneschi
GRGergely Róna
Gergely Róna
NZNan Zhou
Nan Zhou
YJYeon-Tae Jeong
Yeon-Tae Jeong
SJShaowen Jiang
Shaowen Jiang
MPMichele Pagano
Michele Pagano


13 April 2020 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
SSSnahlata Singh
Snahlata Singh
SKSushil Kumar
Sushil Kumar
RSRatnesh Kumar Srivastava
Ratnesh Kumar Srivastava
ANAjeya Nandi
Ajeya Nandi
GTGatha Thacker
Gatha Thacker
RCRumela Chakrabarti
Rumela Chakrabarti

12 August 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MGMaria Guillamot
Maria Guillamot
DODahmane Ouazia
Dahmane Ouazia
IDIgor Dolgalev
Igor Dolgalev
SYStephen T. Yeung
Stephen T. Yeung
NKNikos Kourtis
Nikos Kourtis
IAIannis Aifantis
Iannis Aifantis

18 July 2019 in Metallomics
Verified
Journal Article
Open access
PDF file
YKYe-Jin Kim
Ye-Jin Kim
GBGavin J. Bond
Gavin J. Bond
TTTiffany Tsang
Tiffany Tsang
JPJessica M. Posimo
Jessica M. Posimo
LBLuca Busino
Luca Busino
DBDonita C. Brady
Donita C. Brady
Copper (Cu) is a tightly regulated micronutrient that functions as a structural or catalytic cofactor for specific proteins essential for a diverse array of biological processes. While the study of the extremely rare genetic diseases, Menkes and Wilson, has highlighted the requirement for proper Cu acquisition and elimination in biological systems for cellular growth and proliferation, the importance of dedicated Cu transport systems, like the Cu chaperones ATOX1 and CCS, in the pathophysiology of cancer is not well defined. We found that ATOX1 was significantly overexpressed in human blood, breast, and skin cancer samples, while CCS was significantly altered in human brain, liver, ovarian, and prostate cancer when compared to normal tissue. Further analysis of genetic expression data in Cancer Cell Line Encyclopedia (CCLE) revealed that ATOX1 is highly expressed in melanoma cell lines over other cancer cell lines. We previously found that Cu is required for BRAFV600E-driven MAPK signaling and melanomagenesis. Here we show that genetic loss of ATOX1 decreased BRAFV600E-dependent growth and signaling in human melanoma cell lines. Pharmacological inhibition of ATOX1 with a small molecule, DCAC50, decreased the phosphorylation of ERK1/2 and reduced the growth of BRAF mutation-positive melanoma cell lines in a dose-dependent manner. Taken together, these results suggest that targeting the Cu chaperone ATOX1 as a novel therapeutic angle in BRAFV600E-driven melanomas.

9 July 2018 in eLife
Verified
Journal Article
Open access
GRGergely Róna
Gergely Róna
DRDomenico Roberti
Domenico Roberti
YYYandong Yin
Yandong Yin
JPJulia K Pagan
Julia K Pagan
HHHarrison Homer
Harrison Homer
MPMichele Pagano
Michele Pagano
The mammalian FBXL10-RNF68-RNF2 ubiquitin ligase complex (FRRUC) mono-ubiquitylates H2A at Lys119 to repress transcription in unstressed cells. We found that the FRRUC is rapidly and transiently recruited to sites of DNA damage in a PARP1- and TIMELESS-dependent manner to promote mono-ubiquitylation of H2A at Lys119, a local decrease of H2A levels, and an increase of H2A.Z incorporation. Both the FRRUC and H2A.Z promote transcriptional repression, double strand break signaling, and homologous recombination repair (HRR). All these events require both the presence and activity of the FRRUC. Moreover, the FRRUC and its activity are required for the proper recruitment of BMI1-RNF2 and MEL18-RNF2, two other ubiquitin ligases that mono-ubiquitylate Lys119 in H2A upon genotoxic stress. Notably, whereas H2A.Z is not required for H2A mono-ubiquitylation, impairment of the latter results in the inhibition of H2A.Z incorporation. We propose that the recruitment of the FRRUC represents an early and critical regulatory step in HRR.